Abstract
Theta burst stimulation (TBS) is approved and widely used in the treatment of treatment resistant-major depression. More recently, accelerated protocols delivering multiple treatments per day have been shown to be efficacious and potentially enhance outcomes compared to once daily protocols. Meanwhile, bilateral treatment protocols have also been increasingly tested to enhance outcomes. Here, we examined the efficacy and safety of accelerated bilateral TBS in major depressive disorder (MDD). In this open label pilot study, 25 patients with MDD (60%: women; mean age (SD): 45.24 (12.22)) resistant to at least one antidepressant, received bilateral TBS, consisting of 5 sequential bilateral intermittent TBS (iTBS) (600 pulses) and continuous TBS (cTBS) (600 pulses) treatments delivered to the left and right dorsolateral prefrontal cortex (DLPFC), respectively, daily for 5 days at 120% resting motor threshold. Outcome measures were post-treat treatment changes at day 5 and 2-weeks in Hamilton Depression Rating Scale (HDRS-17) scores and response (≥ 50% reduction from the baseline scores) and remission (≤ 7) rates. There was a significant reduction in HDRS scores at day 5 (p < 0.001) and 2-weeks post treatment (p < 0.001). The response rates increased from 20% at day 5 to 32% at 2-weeks post treatment suggesting delayed clinical effects. However, reduction in symptom scores between two post treatment endpoints was non-significant. 60% of patients could not tolerate the high intensity stimulation. No major adverse events occurred. Open label uncontrolled study with small sample size. These preliminary findings suggest that accelerated bilateral TBS may be clinically effective and safe for treatment resistant depression. Randomized sham-controlled trials are needed to establish the therapeutic role of accelerated bilateral TBS in depression.
Trial registration: ClinicalTrials.gov, NCT10001858.
Similar content being viewed by others
Data availability
Data that support the findings of this study are available from the corresponding author upon reasonable request.
Code availability
No computer code or algorithm was used in this study.
References
McClintock SM, Reti IM, Carpenter LL et al (2018) Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 79:3651. https://doi.org/10.4088/JCP.16cs10905
Milev RV, Giacobbe P, Kennedy SH et al (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder:. Neurostimulation treatments. Can J Psychiatry 61:561–575. https://doi.org/10.1177/0706743716660033
Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS (2016) The clinical tms society consensus review and treatment recommendations for tms therapy for major depressive disorder. Brain Stimul 9:336–346. https://doi.org/10.1016/j.brs.2016.03.010
Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J (2018) Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (Three-D): a randomised non-inferiority trial. Lancet 391:1683–1692. https://doi.org/10.1016/s0140-6736(18)30295-2
Voigt JD, Leuchter AF, Carpenter LL (2021) Theta burst stimulation for the acute treatment of major depressive disorder: a systematic review and meta-analysis. Transl Psychiatry 11:330. https://doi.org/10.1038/s41398-021-01441-4
Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC (2005) Theta burst stimulation of the human motor cortex. Neuron 45:201–206. https://doi.org/10.1016/j.neuron.2004.12.033
Huang YZ, Chen RS, Rothwell JC, Wen HY (2007) The after-effect of human theta burst stimulation is nmda receptor dependent. Clin Neurophysiol 118:1028–1032. https://doi.org/10.1016/j.clinph.2007.01.021
Suppa A, Huang YZ, Funke K, Ridding MC, Cheeran B, Di Lazzaro V, Ziemann U, Rothwell JC (2016) Ten years of theta burst stimulation in humans: established knowledge, unknowns and prospects. Brain Stimul 9:323–335. https://doi.org/10.1016/j.brs.2016.01.006
Berlim MT, McGirr A, Rodrigues Dos Santos N, Tremblay S, Martins R (2017) Efficacy of theta burst stimulation (TBS) for major depression: an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res 90:102–109. https://doi.org/10.1016/j.jpsychires.2017.02.015
Brunoni AR, Chaimani A, Moffa AH, Razza LB, Gattaz WF, Daskalakis ZJ, Carvalho AF (2017) Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psychiat 74(2):143–152. https://doi.org/10.1001/jamapsychiatry.2016.3644
Li CT, Chen MH, Juan CH, Huang HH, Chen LF, Hsieh JC, Tu PC, Bai YM, Tsai SJ, Lee YC, Su TP (2014) Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study. Brain 137:2088–2098. https://doi.org/10.1093/brain/awu109
Li CT, Cheng CM, Chen MH, Juan CH, Tu PC, Bai YM, Jeng JS, Lin WC, Tsai SJ, Su TP (2020) Antidepressant efficacy of prolonged intermittent theta burst stimulation monotherapy for recurrent depression and comparison of methods for coil positioning: a randomized, double-blind, sham-controlled study. Biol Psychiatry 87:443–450. https://doi.org/10.1016/j.biopsych.2019.07.031
Caulfield KA, Fleischmann HH, George MS, McTeague LM (2022) A transdiagnostic review of safety, efficacy, and parameter space in accelerated transcranial magnetic stimulation. J Psychiatr Res 152:384–396. https://doi.org/10.1016/j.jpsychires.2022.06.038
Cole EJ, Phillips AL, Bentzley BS et al (2022) Stanford neuromodulation therapy (SNT): A double-blind randomized controlled trial. Am J Psychiatry 179:132–141. https://doi.org/10.1176/appi.ajp.2021.20101429
Sonmez AI, Camsari DD, Nandakumar AL, Voort JLV, Kung S, Lewis CP, Croarkin PE (2019) Accelerated TMS for depression: a systematic review and meta-analysis. J Psychiatry Res 273:770–781. https://doi.org/10.1016/j.psychres.2018.12.041
Chen L, Thomas EHX, Kaewpijit P et al (2021) Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial. Brain Stimul 14:1095–1105. https://doi.org/10.1016/j.brs.2021.07.018
(2013) Diagnostic and statistical manual of mental disorders, 5th ed. American Psychiatric Association, Washington
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62. https://doi.org/10.1136/jnnp.23.1.56
Fitzgerald PB, Daskalakis ZJ (2012) A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression. Brain Stimul 5(3):287–296. https://doi.org/10.1016/j.brs.2011.03.006
Duprat R, Desmyter S, de Rudi R et al (2016) Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission? J Affect Disord 200:6–14. https://doi.org/10.1016/j.jad.2016.04.015
Fitzgerald PB, Hoy KE, Elliot D, Susan McQueen RN, Wambeek LE, Daskalakis ZJ (2018) Accelerated repetitive transcranial magnetic stimulation in the treatment of depression. Neuropsychopharmacology 43:1565–1572. https://doi.org/10.1038/s41386-018-0009-9
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389. https://doi.org/10.1192/bjp.134.4.382
Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ (2011) The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168:1266–1277. https://doi.org/10.1176/appi.ajp.2011.10111704
Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P (1995) A scale for the assessment of hedonic tone the Snaith–Hamilton pleasure scale. Br J Psychiatry 167:99–103. https://doi.org/10.1192/bjp.167.1.99
Ware JE Jr, Sherbourne CD (1992) The mos 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483. https://doi.org/10.1097/00005650-199206000-00002
American Psychiatric Association (2013) American psychiatric association releases DSM-5. APA, Washington. https://doi.org/10.1176/appi.books.9780890425596
Thase ME, Rush AJ (1997) When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 58:23–29
Bech P, Boyer P, Germain JM, Padmanabhan K, Haudiquet V, Pitrosky B, Tourian KA (2010) HAMD-17 and HAMD-6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder. Pharmacopsychiatry 43:271–276. https://doi.org/10.1055/s-0030-1263173
Baeken C, Duprat R, Wu G-R, De Raedt R (2018) Accelerated intermittent theta burst stimulation rapidly attenuates depressive symptoms and suicide ideation in major depression: insights from brain perfusion and functional connectivity. Biol Psychiatry 83:S54. https://doi.org/10.1016/j.biopsych.2018.02.151
Plewnia C, Pasqualetti P, Große S, Schlipf S, Wasserka B, Zwissler B, Fallgatter A (2014) Treatment of major depression with bilateral theta burst stimulation: a randomized controlled pilot trial. J Affect Disord 156:219–223. https://doi.org/10.1016/j.jad.2013.12.025
Prasser J, Schecklmann M, Poeppl TB, Frank E, Kreuzer PM, Hajak G, Rupprecht R, Landgrebe M, Langguth B (2015) Bilateral prefrontal rTMS and theta burst TMS as an add-on treatment for depression: a randomized placebo controlled trial. World J Biol Psychiatry 16:57–65. https://doi.org/10.3109/15622975.2014.964768
Blumberger DM, Vila-Rodriguez F, Wang W et al (2021) A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression: a Canadian rTMS treatment and biomarker network in depression (CARTBIND) study. Brain Stimul 14:1447–1455. https://doi.org/10.1016/j.brs.2021.09.003
Caulfield KA, Brown JC (2022) The problem and potential of TMS’ infinite parameter space: a targeted review and road map forward. Front Psychiatry 13:867091. https://doi.org/10.3389/fpsyt.2022.867091
McCalley DM, Lench DH, Doolittle JD, Imperatore JP, Hoffman M, Hanlon CA (2021) Determining the optimal pulse number for theta burst induced change in cortical excitability. Sci Rep 11:8726. https://doi.org/10.1038/s41598-021-87916-2
Abraham WC, Bear MF (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19:126–130. https://doi.org/10.1016/s0166-2236(96)80018-x
Kramár EA, Babayan AH, Gavin CF, Cox CD, Jafari M, Gall CM, Rumbaugh G, Lynch G (2012) Synaptic evidence for the efficacy of spaced learning. Proc Natl Acad Sci USA 109:5121–5126. https://doi.org/10.1073/pnas.1120700109
Thomson AC, de Graaf TA, Kenis G, Rutten BPF, Schuhmann T, Sack AT (2019) No additive meta plasticity effects of accelerated iTBS with short inter-session intervals. Brain Stimul 12:1301–1303. https://doi.org/10.1016/j.brs.2019.05.012
Fitzgerald PB, Hoy KE, Anderson RJ, Daskalakis ZJ (2016) A study of the pattern of response to rTMS treatment in depression. Depress Anxiety 33:746–753
Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM et al (2019) Concomitant medication use and clinical outcome of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder. Brain Behav 9:e01275
Weigand A, Horn A, Caballero R, Cooke D, Stern AP, Taylor SF, Press D, Pascual-Leone A, Fox MD (2018) Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol Psychiatry 84:28–37. https://doi.org/10.1016/j.biopsych.2017.10.028
Fox MD, Buckner RL, White MP, Greicius MD, Pascual-Leone A (2012) Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry 72(7):595–603. https://doi.org/10.1016/j.biopsych.2012.04.028
Blumberger DM, Mulsant BH, Thorpe KE et al (2022) Effectiveness of standard sequential bilateral repetitive transcranial magnetic stimulation vs bilateral theta burst stimulation in older adults with depression: the FOUR-D randomized noninferiority clinical trial. JAMA Psychiat 79(11):1065–1073. https://doi.org/10.1001/jamapsychiatry.2022.2862
Carrozzino D, Patierno C, Fava GA, Guidi J (2020) The Hamilton rating scales for depression: a critical review of clinimetric properties of different versions. Psychother Psychosom 89:133–150. https://doi.org/10.1159/000506879
Boucher PO, Ozdemir RA, Momi D, Burke MJ, Jannati A, Fried PJ, Pascual-Leone A, Shafi MM, Santarnecchi E (2021) Sham-derived effects and the minimal reliability of theta burst stimulation. Sci Rep 11:21170. https://doi.org/10.1038/s41598-021-98751-w
Razza LB, Moffa AH, Moreno ML, Carvalho AF, Padberg F, Fregni F, Brunoni AR (2018) A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials. Prog Neuropsychopharmacol Biol Psychiatry 81:105–113. https://doi.org/10.1016/j.pnpbp.2017.10.016
Acknowledgements
Funding for the study was provided by a grant from Hotchkiss Brain Institute/ Mathison Centre Pilot Research Fund Program (PFUN), affiliated with Cumming School of Medicine (CSM), University of Calgary, Calgary, Alberta, Canada. The infra structure support was provided by Non-invasive Neurostimulation Network (N3) – Hotchkiss Brain Institute, University of Calgary. Partial data were presented as a poster at the Society of Biological Psychiatry April 2022 annual meeting.
Funding
Funding for the study was provided by a grant from Hotchkiss Brain Institute/Mathison Centre Pilot Research Fund Program (PFUN), affiliated with Cumming School of Medicine (CSM), University of Calgary, Calgary, Alberta, Canada. The infra structure support was provided by Non-invasive Neurostimulation Network (N3)—Hotchkiss Brain Institute, University of Calgary.
Author information
Authors and Affiliations
Contributions
RR and EB designed the study and wrote the grant. BS designed the TBS protocol. RR, LM recruited the patients, collected clinical data. BS and JC helped to perform TBS treatment. RR and HH planned the analysis. RR interpreted the results and wrote the manuscript. AM provided material support and critical review of the manuscript. All authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Ramasubbu has received honorarium for serving in the advisory committee of Astra Zeneca, Lund beck, Janssen, and Otsuka. He also received investigator-initiated grant from Astra Zeneca and Pfizer. Dr. McGirr has received honorarium for serving on an advisory board for Allergan Canada and is a founder of MCGRx Corp. The funding agency had no influence on the design, and conduct of the study including collection, analysis and interpretation of the data, and preparation, review, or approval of the manuscript. Other authors declare no potential conflict of interest.
Ethical approval
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
Consent to participate
Informed consent was obtained from all individual participants.
Consent to publish
All participants provided signed informed consent regarding publishing their data.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ramasubbu, R., Brown, E.C., Selby, B. et al. Accelerated sequential bilateral theta-burst stimulation in major depression: an open trial. Eur Arch Psychiatry Clin Neurosci 274, 697–707 (2024). https://doi.org/10.1007/s00406-023-01648-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-023-01648-0